MSB 7.69% $1.19 mesoblast limited

No. Mesoblast has submitted a BLA for Ryoncil aGVHD, they...

  1. 12,393 Posts.
    lightbulb Created with Sketch. 3370
    No.

    Mesoblast has submitted a BLA for Ryoncil aGVHD, they received a CRL and now are seeking a Type A meeting with the FDA to discuss a possible Accelerated Approval pathway.

    Separately, they are doing a RCT of 300 patients for Covid-19 ARDS using Rem-L (this is what we are currently talking about)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.